NEW YORK -- A vaccine for the new coronavirus should be ready for emergency use in early 2021, American drugmaker Johnson & Johnson announced Monday.
The pharmaceutical company has selected a lead candidate and two backups from 10 variants it has been working with since January. Clinical trials will begin in September at the latest.
